Showing results (231-240 of 6,708) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|April 21, 2020
Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer CellsFeng Gao, Ming Li, Wenbin Liu, et al.Oncotargets and Therapy|April 21, 2020
Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLCYunyao Ye, Jingyao Gu, Pei Liu, et al.Oncotargets and Therapy|April 21, 2020
CircRNA hsa_circ_0087862 Acts as an Oncogene in Non-Small Cell Lung Cancer by Targeting miR-1253/RAB3D AxisLin Li, Ke Wan, Linkai Xiong, et al.Oncotargets and Therapy|April 21, 2020
Erratum: Long Non-Coding RNA PVT1 Regulates BAMBI to Promote Tumor Progression in Non-Small Cell Lung Cancer by Sponging miR-17-5p [Corrigendum]Oncotargets and Therapy|April 21, 2020
Upregulation of miR-211 Promotes Chondrosarcoma Development via Targeting Tumor Suppressor VHLChangbao Chen, Aixian Tian, Hua Zhou, et al.Oncotargets and Therapy|April 21, 2020
Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 AxisZhi Tao Jiang, Yi Han, Xiao Yan Liu, et al.Oncotargets and Therapy|August 16, 2016
Clinical significance of TIPE expression in gastric carcinomaRuyi Hu, Xingfeng Qiu, Shifu Hong, et al.Oncotargets and Therapy|August 16, 2016
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studiesJietao Ma, Xin Sun, Letian Huang, et al.Oncotargets and Therapy|August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinomaMichael Davidson, Elizabeth C Smyth, David CunninghamOncotargets and Therapy|August 16, 2016
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II studyYing Mu, Wei-Hua Wang, Jia-Ping Xie, et al.Pageof 671